London, United Kingdom · Founded 2021 · Privately Held (backing)
Operator of a biotechnology company intended to deliver effective therapeutics and de-risk the pharma pipeline by leveraging the synergy between drugs and bacteria. BioCorteX is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $13.3 million in Mar 2023. It has raised $5.2 million.
Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$5.2M
Last round
—
Cap table — not yet on record
BioCorteX's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioCorteX with a free account
·Watch BioCorteX: the Monday email on marks, rounds and moves
